Basket Study at Providence Medical Group

Providence Medical Group is currently enrolling patients for the following basket studies:

A Phase 1/2 Study of Galinpepimut-S in Combination with Pembrolizumab (MK-3475) in Patients with Selected Advanced Cancers (SELLAS)

Treatment agent: Galinpepimut-S (WT1 immunotx) + pembro
PI: Jarrod Holmes, MD
Study Coordinator: Tracy Foster // // (707) 521-3836 ext. 1136
Resources and Links: NCT No: NCT03761914